TABLE 6.
Secondary clinical endpoints
| Secondary clinical endpoints | Convalescent plasma (N = 29) | Controls (N = 48) | P-value |
|---|---|---|---|
| Hospital length of stay, median (Q1, Q3) | 8 (6, 10) | 7 (4.75, 12.25) | 0.987 |
| ICU length of stay, median (Q1, Q3) | 0 (0, 0) | 0 (0, 2) | 0.244 |
| ICU-free days, median (Q1, Q3) | 28 (28, 28) | 28 (23.75, 28) | 0.238 |
| Ventilator-free days, median (Q1, Q3) | 28 (28, 28) | 28 (28, 28) | 0.412 |
| Need for renal replacement therapy, n (%) | 1 (3.4%) | 1 (2.1%) | >0.99 |
| Need for extracorporeal membrane oxygenation (ECMO) | 1 (3.4%) | 0 (0.0%) | 0.377 |